Facebook Scoffs at Yahoo Rumor and 4 Hot Stocks Making Market Waves

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Ligand Pharmaceuticals Incorpor (NASDAQ:LGND) partner GlaxoSmithKline (NYSE:GSK) stated that the U.S. FDA approved Promacta to treat thrombocytopenia in patients diagnosed with chronic hepatitis C, enabling them to initiate and maintain interferon-based therapy. Promacta is the first supportive care treatment that has been made available to patients ineligible or poor candidates for interferon-based therapy as a result of their low blood platelet counts. Promacta together with interferon-based therapy is proven to improve a patient’s probability of achieving an ongoing virologic response or viral cure.

Intuitive Surgical, Inc. (NASDAQ:ISRG) along with Canada’s Titan Medical (TTXF) developed surgical robots enabling surgery to be performed with fewer and smaller incisions, according to a The New York Times report on Saturday.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Facebook, Inc. (NASDAQ:FB) and Yahoo (NASDAQ:YHOO) have not been conversing regarding either building a search engine together or forming a search alliance, sources have informed AllThingsD. Additionally, it is reported that sources “scoffed” at a report in the Telegraph claiming that the two had been in discussions. Furthermore, AllThingsD has stated that Yahoo is “not anywhere near” completing its search partnership with Microsoft (NASDAQ:MSFT), although CEO Marissa Mayer conversed with Microsoft about improved performance.

GlaxoSmithKline plc (NYSE:GSK) and Ligand Pharmaceuticals (NASDAQ:LGND) stated that the U.S. FDA approved Promacta to treat thrombocytopenia in patients diagnosed with chronic hepatitis C, enabling them to initiate and maintain interferon-based therapy. Promacta is the first supportive care treatment that has been made available to patients ineligible or poor candidates for interferon-based therapy as a result of their low blood platelet counts. Promacta together with interferon-based therapy is proven to improve a patient’s probability of achieving an ongoing virologic response or viral cure.

Bank of America (NYSE:BAC): China reduced the capital-reserve requirement for securities firms has been lowered by China, and the range of financial products they may invest in has been expanded, as the domestic stock market continues to be sluggish, according to the Wall Street Journal. Now, brokerages engaging in asset management must set aside as reserves 1 to 2 preserves the amount under management, which has declined from the previous 2 to 4 percent, the China Securities Regulatory Commission reports.

Don’t Miss: Google Leaves Online Video Competitors Fighting for Scraps.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business